Skip to main content
. 2022 Oct 13;3(4):e181. doi: 10.1002/mco2.181

FIGURE 1.

FIGURE 1

Timeline for the US FDA‐approved small molecule inhibitors targeting the cancers. Figure created with BioRender.com